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SObjective: Surgical site infections after cardiothoracic surgery substantially increase the risk for illness, mor-
tality, and costs. Surveillance of surgical site infections might assist in the prevention of these infections. This
study describes the Dutch surveillance methods and results of data collected between 2002 and 2007.
Methods: Three cardiothoracic procedures were included: coronary artery bypass graft procedures, valve sur-
gery, and a combination of coronary artery bypass graft procedures with concomitant valve surgery. The surgical
site infections were divided into sternal and harvest-site infections. Postdischarge surveillance of surgical site
infections was mandatory for sternal wounds and elective for harvest-site wounds, with a follow-up period of
42 postoperative days. Multivariate logistic regression was used for risk factor analysis of coronary artery bypass
grafts, with adjustment for random variation among hospitals.
Results: Eight of the 16 Dutch cardiothoracic centers participated and collected data on 4066 procedures and
183 surgical site infections, revealing a surgical site infection rate of 2.4% for sternal wounds and 3.2% for har-
vest sites. Sixty-one percent of all surgical site infections were recorded after discharge. For sternal surgical site
infections after coronary artery bypass graft procedures, the significant risk factors were rethoracotomy, diabe-
tes, preoperative length of stay, and obesity; for harvest-site infections, the most relevant risk factor was a long
time on extracorporeal circulation. Adjusted surgical site infection rates regarding coronary artery bypass graft
procedures varied between hospitals from 0.0% to 9.7%.
Conclusions: Large differences were found in surgical site infection rates between Dutch hospitals, which in-
dicate room for improvement. The follow-up of patients after hospital discharge reduces underestimation of
surgical site infection rates. (J Thorac Cardiovasc Surg 2011;141:899-904)In The Netherlands, about 16,000 patients undergo cardio-
thoracic surgery in one of 16 specialized hospitals every
year. Surgical-site infections (SSIs) after cardiothoracic
procedures substantially increase the risk for mortality, ill-
ness, and costs. Hollenbeak and colleagues1 reported that
a deep sternal infection increased the length of hospital
stay by 20 days, led to a 36 times increased risk of dying,
and increased costs with $19,000. The proportion of pa-
tients undergoing cardiothoracic procedures at risk for in-
fection is increasing because of the aging population and
the growing number of patients with conditions like obesity
or diabetes mellitus. SSIs after cardiothoracic surgery
should be prevented where possible. It has been demon-
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The Journal of Thoracic and Cagood hygiene measures, working according to infection
prevention guidelines, and administration of antimicrobial
prophylaxis appropriately, surveillance of SSIs might assist
in the prevention of these infections.2-6 Important aspects
of SSI surveillance are clear infection criteria and
a standardized method for tracing infections. For reliable
comparison of infection rates between hospitals, the rates
should be corrected for differences in risk factors or other
disturbing factors.
In TheNetherlands, SSI surveillancewas set upwithin the
national nosocomial infection surveillance network Preven-
tie van Ziekenhuisinfecties door Surveillance (PREZIES) in
1996.7 Because the factors that influence the risk for an SSI
after cardiothoracic surgery differ from those influencing
SSI risk after other surgical procedures (eg, time on extra-
corporeal circulation), a separate surveillance protocol was
developed for cardiothoracic surgery in 2001. This study de-
scribes the surveillance methods and the results of data col-
lected between 2002 and 2007. The degree of participation
might indicate the feasibility of the surveillance, how
much value hospitals attach to it, or both. Variation between
hospitals in SSI incidence might indicate possible room for
improvement. Furthermore, the resultsmight reveal possible
patient groups at high risk for SSIs after cardiothoracic sur-
gery. Overall, the results can be used for improvement of the
surveillance methodology and for specific infection preven-
tion improvement activities in the hospitals.rdiovascular Surgery c Volume 141, Number 4 899
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
ECC ¼ extracorporeal circulation
NNIS ¼ National Nosocomial Infection
Surveillance
PDS ¼ postdischarge surveillance
PREZIES ¼ Preventie van Ziekenhuisinfecties
door Surveillance
SSI ¼ surgical site infection
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SMATERIALS AND METHODS
In 2002, a pilot study took place regarding the surveillance of SSIs after
cardiothoracic surgery in 7 Dutch hospitals. After a few adjustments, the
definite protocol was agreed on in 2003. For reliable comparison of infec-
tion rates between hospitals, only clearly defined procedures that are regu-
larly performed should be included in surveillance systems. Therefore the
Dutch surveillance focused on 3 types of cardiothoracic procedures: coro-
nary artery bypass graft (CABG) procedures, valve surgery, and a combina-
tion of CABG procedures and concomitant valve surgery. All patients
undergoing the 3 selected types of cardiothoracic procedures must be in-
cluded in the PREZIES surveillance to avoid selection bias.
When these procedures are performed, the sternum is always opened.
With CABG procedures, donor grafts are often harvested from the leg (sa-
phenous vein) or arm (radial artery), which results in another incision that
might get infected. In addition, internal thoracic arteries can be used as
bypass grafts.
The standardized criteria for an SSI developed by the US Centers for
Disease Control and Prevention were applied. SSIs after cardiothoracic sur-
gery were classified as sternal wound infections or harvest-site infections.
Sternal infections related to the skin were considered superficial SSIs, and
infections of the sternum,mediastinum, or both were considered deep SSIs.
Harvest-site infections were classified as superficial and deep SSIs, with
deep incisional and organ-space infections combined into deep SSIs.
Based on the international literature and the results of the Dutch pilot
study, the following risk factors were included in the final PREZIES proto-
col: age, sex, insulin-dependent diabetes, obesity (body mass index 30),
preoperative duration of hospitalization, whether the operation was per-
formed on an emergency basis, application of both internal thoracic ar-
teries, use of a heart–lung machine (and, if so, the time on extracorporeal
circulation [ECC]), lowest body temperature during the operation (nasal
measurement), duration of intensive care admission, and rethoracotomy
(if not executed because of an infection). In case a heart–lung machine
was used, the 75th percentile of ECC time was calculated in minutes per
type of procedure by using the current data. The registration of nasal car-
riage of Staphylococcus aureus and culture results (at most 3 microorgan-
isms per infection) was voluntary. Both for screening and clinical isolates,
no distinction is made between methicillin-susceptible S aureus or
methicillin-resistant S aureus. The American Society of Anesthesiologists
physical status classification, wound contamination class, and duration of
the operation (which are included in the American National Nosocomial
Infection Surveillance [NNIS] risk index) were not included in the protocol
because the predictability of these items for an SSI is poor for CABG pro-
cedures.8-10
Because many cardiothoracic surgery patients are referred from another
hospital, the patients often will return to that hospital shortly after the op-
eration. Therefore many SSIs will develop after patients are discharged
from the specialized heart center where the procedure took place. To min-
imize the risk for missing SSIs, within the PREZIES network, postdi-
scharge surveillance (PDS) of SSIs after cardiothoracic procedures was900 The Journal of Thoracic and Cardiovascular Surgmandatory for sternal wounds and elective for harvest-site wounds. A
follow-up period of 42 postoperative days was assigned mainly for practi-
cal reasons because most patients returned to the heart center for control at
6 weeks postoperatively. The recommended method by PREZIES for PDS
of sternal wounds was addition of a special registration card to the outpa-
tient medical record on which the surgeon noted clinical symptoms and
whether a patient had an SSI according to the definitions; an alternative
method was examination of the outpatient medical record after the
follow-up period had elapsed.11 A prerequisite for this alternative method
was that the status of the wound had to be clearly described in the records.
For postdischarge follow-up of harvest sites, the advicewas to give patients
a questionnaire that they should return in case of signs of an SSI or other-
wise after 6 weeks. In case PDS was performed, the date of PDS could be
registered voluntarily. The date of PDS indicated the most recent date on
which information was gathered from the patient (eg, the date of postdi-
scharge check-up or the date of infection). The duration of follow-up
was determined by the number of days between the operation and the
date of PDS.
Every time a hospital sent in data (on average once a year), it received
a feedback report per surgical procedure (CABG, valve surgery, or a com-
bination of these) including infection rates for each type of SSI separately
(ie, sternal SSIs and harvest-site SSIs). The report also provided expected
SSI rates adjusted for the most relevant risk factor or factors. Furthermore,
the feedback report included figures showing the SSI rate for each partici-
pating hospital per type of procedure and per type of SSI. Within the par-
ticipating hospitals, feedback reports were usually spread among and
discussed with the infection control committee, physicians, managers,
and other involved staff.
Within the Dutch PREZIES network, participation is voluntary, and
hospital-specific data are kept confidential. Validation visits by a PREZIES
team member to each participating hospital take place every 3 years and
provide evidence for the reliability and accuracy of the surveillance
data.12 The process of surveillance, including the quality of the method
of data collection, is validated by means of a structured interview. The
use of SSI criteria is validated by review of 25 medical records, with the
judgment of the validation team as the criterion standard. Yearly workshops
for participants are organized by the PREZIES network to provide informa-
tion, exchange experiences and tips and possible pitfalls regarding the sur-
veillance, discuss possible infection prevention strategies, and practice
cases studies.
Multivariate risk factor analysis was only performed for CABG proce-
dures because of the small number of recorded SSIs after valve surgery and
after a combination of CABG with concomitant valve surgery. The analy-
ses were executed separately for harvest-site and sternal SSIs, but superfi-
cial and deep SSIs were combined. Variables with a P value of less than .2
for their univariate association with SSI were candidates for multivariable
logistic regression analysis. In the present multicenter study, patients were
clustered by hospital. This level of hierarchy can introduce additional sour-
ces of variability and correlation (eg, by hospital-specific treatment policies
or risk factors). Therefore a random coefficient model was used to adjust
the risk estimates for random variation among hospitals. Manually forward
selection was performed by using the likelihood ratio test. Associations be-
tween SSIs and exposure to risk factors were estimated by odds ratios and
95% confidence intervals.
A Kaplan–Meier survival curve was created to present the duration of
follow-up of all patients.
All analyses were performed with SAS forWindows software (SAS 9.1;
SAS Institute, Inc, Cary, NC).RESULTS
Seven of the 16 Dutch specialized cardiothoracic centers
participated in the PREZIES pilot surveillance on SSIs in
2002. Afterward, 3 of these hospitals plus 1 additionalery c April 2011
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Shospital participated using the final protocol. Because the
protocol of the pilot study only slightly differed from the fi-
nal protocol, all data from 2002 to 2007 were included to
increase the reliability. Between 2002 and 2007, 8 hospitals
collected data on 4066 patients undergoing CABG surgery,
valve surgery, or a combination of CABG surgery with con-
comitant valve surgery.
Table 1 describes the characteristics of the patient popu-
lation. The number of procedures per hospital varied from
108 to 1146. The data revealed some remarkable differences
in patient and procedure characteristics between hospitals.
For example, the percentage of CABG procedures in which
a heart–lung machine was used varied between 68% and
100%, and if used, the median ECC time varied between
64 and 123 minutes. Bilateral thoracic arteries were used
in 0% to 16% of CABG procedures, with an outlier of
43%. In CABG procedures, the percentage of patients
with a body mass index of 30 kg/m2 or greater varied from
18.5% to 28%. Overall, the median lowest body tempera-
ture varied between 30C and 35C among the hospitals.
In total, 4066 surgical procedures and 183 SSIs were reg-
istered. Fifty-three deep sternal SSIs (cumulative incidence,
1.3%) and 44 superficial sternal SSIs (cumulative incidence,
1.1%) were included. Of the 2691 patients with a harvest
site, 86 had an SSI at the harvest site (cumulative incidence,
3.2%), of which 13 were deep SSIs. The cumulative inci-
dences of SSIs per type of procedure are shown in Table 2.
Six patients had both a sternal and a harvest-site SSI.
The variation in SSI incidence between hospitals was
larger for harvest-site SSIs than for sternal SSIs. This might
reflect the fact that for harvest sites, PDS was voluntary, andTABLE 1. Characteristics of patients undergoing cardiothoracic
procedures
Overall
CABG
surgery
Valve
surgery
CABG/valve
surgery
No. of procedures 4066 2732 808 526
Male sex (%) 71 76 56 69
Median age (y) 67 67 66 71
Emergency procedure (%) 7 7 6 4
Preoperative LOS 2 d (%) 33 35 27 31
Body mass index
30 kg/m2 (%)
20 21 16 17
Diabetes (%) 7 9 3 6
Lowest body temperature
>34C (%)
25 27 21 20
ICU LOS 2 d (%) 49 44 57 74
Rethoracotomy (%) 9 7 13 14
Heart–lung machine (%) 92 88 100 100
Median duration of
perfusion (min)
109 99 123 165
Use of bilateral thoracic
arteries (%)
6 9 0 3
CABG, Coronary artery bypass graft; LOS, length of stay; ICU, intensive care unit.
The Journal of Thoracic and Ca3 hospitals did not perform active PDS for these wounds.
Consequently, these 3 hospitals recorded the lowest SSI in-
cidences for harvest sites. For CABG procedures, the ster-
nal SSI incidence varied from 0.0% to 4.5% between
hospitals, and the SSI incidence for harvest sites ranged
from 0.4% to 6.9% between hospitals.
For patients without an SSI, the median length of stay
was 10 days: 9 days for CABG surgery, 10 days for valve
surgery, and 12 days for a combination of CABG and valve
surgery. Regarding CABG surgery, the median duration of
admission for patients with a superficial sternal SSI was
12 days, that for patients with a deep sternal SSI was 19
days, and that for patients with a harvest-site SSI was
10 days. Thus there was a median increase of 3, 10, and 1
days, respectively, compared with patients without an SSI
after CABG surgery. PDS led to the reporting of 24 deep
sternal SSIs (45% of 53), 24 superficial sternal SSIs
(55% of 44), and 64 harvest-site SSIs (74% of 86) after
the patients had left the heart centers. Table 3 shows the
number of SSIs detected during admission and after dis-
charge specifically for CABG procedures.
Figure 1 shows the Kaplan–Meier survival curve of ster-
nal and harvest-site SSIs after the included cardiothoracic
procedures. Regarding the 3889 patients without an SSI,
the date of PDS was missing for 801 patients. In these cases,
the duration of follow-up was determined as the period from
surgical intervention to discharge. Seventy-three percent
(2836) of the 3889 patients without an SSI were followed
for at least 42 postoperative days, which was the surveil-
lance period according to the protocol. The risk for
harvest-site SSIs seemed to be steady during the first 4 post-
operative weeks. The risk for sternal SSIs was highest be-
tween days 6 and 16 postoperatively. The number of days
between surgical intervention and infection hardly differed
between deep and superficial sternal SSIs.
Multilevelmultivariate risk factor analysiswas performed
for CABG procedures (Table 4). For sternal SSIs, the signif-
icant risk factors were rethoracotomy (not executed because
of an infection), diabetes, preoperative length of stay, and
obesity. For harvest-site SSIs, the most relevant risk factor
appeared to be an ECC time of longer than the 75th percen-
tile for CABG procedures, which was 123 minutes.
A culture result was available for 46 (87%) of the
53 deep sternal SSIs and for 26 (59%) of the 44 superficial
SSIs. Fifty-eight percent (49/84) of the isolated microor-
ganisms were identified as staphylococci (37 being
S aureus). For 41 (48%) of the 86 harvest-site SSIs, a culture
result was recorded. Thirty-one percent (19/61) of the iso-
lated microorganisms were identified as staphylococci (15
being S aureus). Of the 514 patients with a positive nose
swab result for S aureus, 31 (6.0%) had an SSI. Of the
1350 patients with a negative nose swab result for S aureus,
53 (3.9%) had an SSI. S aureus was isolated 11 (21%)
times (P ¼ .07).rdiovascular Surgery c Volume 141, Number 4 901
TABLE 2. Cumulative incidence of SSIs per type of procedure
CABG surgery Valve surgery CABG/valve surgery
No.
Cumulative incidence
(95% CI) No.
Cumulative incidence
(95% CI) No.
Cumulative incidence
(95% CI)
No. of procedures 2732 808 526
Sternal SSIs 66 2.4 (1.9–3.1) 14 1.7 (1.0–2.9) 17 3.2 (2.0–5.1)
Deep sternal SSIs 33 1.2 (0.9–1.7) 11 1.4 (0.8–2.4) 9 1.7 (0.9–3.2)
Superficial sternal SSIs 33 1.2 (0.9–1.7) 3 0.4 (0.1–1.1) 8 1.5 (0.8–3.0)
No. of harvest sites 2289 402
Harvest-site SSIs 67 2.9 (2.3–3.7) 19 4.7 (3.0–7.3)
SSI, Surgical site infection; CABG, coronary artery bypass graft; CI, confidence interval.
99.5
100.0
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SDISCUSSION
Advantages of the Dutch surveillance are that specific
risk factors for SSIs after cardiothoracic surgery were in-
cluded, PDS was mandatory for sternal SSIs, and the execu-
tion of the surveillance (including the application of SSI
criteria) was validated in all participating hospitals every
3 years. The extra risk factors seemed relevant, as shown
by means of multivariate logistic regression analyses,
such as rethoracotomy, obesity, diabetes, and ECC time,
which are not included in the regular SSI surveillance in
The Netherlands. Focusing surveillance on a small number
of indicator procedures will save time and allow registration
of procedure-specific relevant risk factors. PDS was impor-
tant because 58% of the registered sternal SSIs and 79% of
the registered harvest-site SSIs developed after the patient
had left the hospital where the operation took place.
A surveillance period of 42 postoperative days was cho-
sen because most patients return to the heart center for con-
trol at 6 weeks postoperatively. However, the American SSI
surveillance methods, developed by the Centers for Disease
Control and Prevention, are accepted and copied by many
countries worldwide. Therefore we decided to adjust our
protocol from January 2009 and changed the surveillance
period to 30 days postoperatively for harvest-site SSIs and
superficial sternal SSIs and 1 year postoperatively for
deep sternal SSIs. Shortening the surveillance period from
42 to 30 days for harvest-site SSIs and superficial sternal
SSIs will decrease the number of recorded SSIs. In the cur-TABLE 3. Number of SSIs detected during admission or after
discharge for CABG procedures
During admission After discharge
Type of SSI No. % No. %
Sternal SSI
Overall 28 42 38 58
Deep 15 45 18 55
Superficial 13 39 20 61
Harvest-site SSI
Overall 14 21 53 79
SSI, Surgical site infection; CABG, coronary artery bypass graft.
902 The Journal of Thoracic and Cardiovascular Surgrent study, 13% of recorded SSIs developed between 30 and
42 days postoperatively.
Our study showed for all included cardiothoracic proce-
dures a cumulative SSI incidence of 2.4% for sternal SSIs
and 3.2% for harvest-site SSIs. For CABG procedures
only, the cumulative SSI incidence was 2.4% for sternal
SSIs and 2.9% for harvest-site SSIs. Large differences
were found between Dutch hospitals, which indicate that
there is room for improvement.
Results from other studies reveal a wide range of SSI in-
cidences after cardiothoracic procedures. However, com-
parisons should be made with caution for several reasons:
different SSI criteria, different duration of follow-up, differ-
ent intensity of PDS, and different types of cardiothoracic
procedures. Because of these pitfalls and because the pri-
mary aim of a national surveillance system is to decrease
the SSI incidence within a country, the focus should be on
following time trends within a country instead of comparing
SSI incidences between countries. However, a decrease in
the SSI incidence might be precluded because the aging
population and the growing number of patients with condi-
tions like obesity or diabetes mellitus probably increase the
infection risk.
In the current study, rethoracotomy (not executed because
of an infection), diabetes, preoperative length of stay, and96.0
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97.5
98.0
98.5
99.0
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FIGURE 1. Kaplan–Meier survival curve of sternal and harvest-site SSIs
after cardiothoracic surgery.
ery c April 2011
TABLE 4. Multilevel multivariate risk factor analyses for CABG
procedures
Type of SSI Risk factor
Odds
ratio 95% CI
P
value
Sternal SSIs Rethoracotomy 5.2 2.5–10.6 .001
Diabetes 2.5 1.1–5.5 .03
Preoperative LOS>3 d 2.1 1.1–4.1 .04
Obesity 2.0 1.03.8 .04
Harvest-site SSIs ECC time>123 min 1.8 0.9–3.7 .08
Based on 2732 procedures for sternal SSIs and 2289 procedures for harvest-site SSIs.
CABG, Coronary artery bypass graft; SSI, surgical site infection; CI, confidence inter-
val; LOS, length of stay; ECC, time on extracorporeal circulation (75th
percentile ¼ 123 minutes).
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Sobesity were related to the development of sternal SSIs, and
a long ECC time was related to the development of harvest-
site SSIs. Preoperative length of stay is probably a marker
for comorbidity. Some other studies found similar risk fac-
tors,13,14 and others showed many other risk factors that are
not recorded within PREZIES (current cigarette smoking,
chronic obstructive pulmonary disease, renal insufficiency,
and postoperative bleeding).8,15-18 However, to keep the
surveillance feasible to many hospitals, the amount of data
to be collected should be limited. PREZIES focuses on
nonimpressionable factors for benchmarking purposes.
From 2009, as part of the safety program ‘‘Prevent injury,
work safe in Dutch hospitals’’ (2008–2012), a bundle of 4
optional process measures was added to the protocol,
including antimicrobial prophylaxis (agent and timing),
preoperative hair removal, normothermia, and frequency of
opening doors in the operating room. In addition, the
EUROScore was added to the protocol as a mandatory item.
The EUROScore includes 9 patient-related factors (eg,
chronic pulmonary disease, neurologic dysfunction, and pre-
vious cardiac surgery), 4 cardiac-related factors (eg, recent
myocardial infarction and pulmonary hypertension), and 4
operation-related factors (eg, postinfarct septal rupture).
The EUROScore was originally developed to predict mortal-
ity risk but has been shown to also predict SSI risk.19 Other
studies often use the NNIS risk index. However, the items
of this index (wound contamination class, duration of opera-
tion, and American Society of Anesthesiologists classifica-
tion) are not strongly related to SSI risk (harvest-site and
sternal SSIs combined) after cardiothoracic surgery.8 In the
present study, no significant risk factors were identified for
harvest-site infections. For these infections, the NNIS risk in-
dex might be relevant after all.9,10,20
Repeatedly, studies have demonstrated that surveillance
contributes to the reduction of SSIs.2,6 In The Netherlands,
the usefulness of SSI surveillance is endorsed by the
Dutch authorities. For instance, the Dutch Healthcare
Inspectorate included SSI surveillance as a hospital-
wide structure indicator in the basic set of Hospital
Performance Indicators from 2004, and in 2008 also
strongly recommended all cardiothoracic centers in TheThe Journal of Thoracic and CaNetherlands to participate in the PREZIES module re-
garding SSIs after cardiothoracic surgery. Furthermore,
recognition is revealed by inclusion of the cardiothoracic
procedures as indicator procedures within the national
safety program ‘‘Prevent injury, work safe in Dutch hos-
pitals’’ (2008–2012), which was developed by the Minis-
try of Health, the Healthcare Inspectorate, the Dutch
Hospitals Association, and others and aims to reach an
SSI rate of less than the 25th percentile of the data col-
lected between 2002 and 2007. Between 2004 and 2008,
each year only 2 or 3 hospitals participated in the SSI
surveillance after cardiothoracic procedures of the PRE-
ZIES network. The above-mentioned efforts have resulted
in 6 of the 16 Dutch cardiothoracic centers participating
in the current surveillance module in 2009. In addition,
publication of variation in SSI rates among hospitals, as
done in this study, indicates room for improvement and
might further increase the awareness in hospitals of the
preventable burden and the usefulness of surveillance
and, with that, the number of hospitals willing to partic-
ipate. Although most of the significant risk factors in
multivariate analysis are a marker of the patient’s health
status, decreasing the number of rethoracotomies and the
ECC time, where possible, will decrease the incidence of
SSIs.
We thank all the infection control practitioners, medical spe-
cialists, and nurses at the participating hospitals for their invalu-
able contribution to the collection of data.
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